Skip to main content
SpringerLink
Log in

RETRACTED ARTICLE: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis

射频消融术与肝切除术治疗乳腺癌肝转移: 系统回顾和meta分析

  • Published:
Journal of Zhejiang University-SCIENCE B Aims and scope Submit manuscript

This article was retracted on 30 April 2022

This article has been updated

Abstract

Objective

To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA) and hepatic resection (HR) for breast cancer liver metastases (BCLMs).

Methods

Studies that had examined the outcomes for both RFA and HR for BCLM were identified by searching the electronic databases PubMed, EMBASE, and the Cochrane Library. Pooled analyzes of the overall survival (OS), disease-free survival (DFS), and short-term outcomes of BCLM were performed.

Results

Patients with BCLM gained many more survival benefits from HR than from RFA with regard to the 3-year OS rate (combined odds ratio (OR) 0.41, 95% confidence interval (CI) 0.29–0.59, P<0.001), 5-year OS rate (combined OR 0.38, 95% CI 0.32–0.46, P<0.001), 3-year DFS (combined OR 0.36, 95% CI 0.27–0.49, P<0.001), and 5-year DFS (combined OR 0.51, 95% CI 0.40–0.66, P<0.001). RFA had fewer postoperative complications (combined OR 0.30, 95% CI 0.20–0.44, P<0.001) and shorter hospital stays (combined OR -9.01, 95% CI -13.49–4.54, P<0.001) than HR.

Conclusions

HR takes precedence over RFA in the treatment of patients with BCLM, considering the better survival rate. RFA gives rise to fewer complications and can be carried out with a shorter hospital stay, compared to HR. RFA should be reserved for patients who are not optimum candidates for resection.

中文概要

目的

评估射频消融术(RFA)和肝切除术(HR)治疗乳腺癌肝转移(BCLM)的效果。

创新点

首次采用meta分析的方法, 精确评估RFA和HR治疗BCLM的效果, 解决不同研究产生不同结论的矛盾。

方法

系统收集截止到2017年3月所有与RFA和HR治疗BCLM的效果相关文献, 评价文献质量、提取数据并计算癌症预后相关指标的优势比(OR)及其95%置信区间(CI)。

结论

HR比RFA对于提高BCLM患者生存率有更大优势RFA并发症少、可重复、患者术后住院时间短, 具有明显微创优势。对于不适合行切除治疗的患者可考虑行RFA治疗。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

References

  • Abraham NS, Byrne CJ, Young JM, et al., 2010. Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol, 63(3):238–245. https://doi.org/10.1016/j.jclinepi.2009.04.005

    Article  Google Scholar 

  • Adam R, Aloia T, Krissat J, et al., 2006. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg, 244(6):897–908. https://doi.org/10.1097/01.sla.0000246847.02058.1b

    Article  Google Scholar 

  • Barral M, Auperin A, Hakime A, et al., 2016. Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients. Cardiovasc Intervent Radiol, 39(6): 885–893. https://doi.org/10.1007/s00270-016-1301-x

    Article  CAS  Google Scholar 

  • Bortolotto C, Macchi S, Veronese L, et al., 2012. Radiofrequency ablation of metastatic lesions from breast cancer. J Ultrasound, 15(3):199–205. https://doi.org/10.1016/j.jus.2012.06.007

    Article  CAS  Google Scholar 

  • Bruners P, Schmitz-Rode T, Günther RW, et al., 2008. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results. Rofo, 180(3):216–222. https://doi.org/10.1055/s-2008-1027184

    Article  CAS  Google Scholar 

  • Carrafiello G, Fontana F, Cotta E, et al., 2011. Ultrasoundguided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases. Radiol Med, 116(7):1059–1066. https://doi.org/10.1007/s11547-011-0697-2

    Article  CAS  Google Scholar 

  • Corona SP, Sobhani N, Ianza A, et al., 2017. Advances in systemic therapy for metastatic breast cancer: future perspectives. Med Oncol, 34(7):119. https://doi.org/10.1007/s12032-017-0975-5

    Article  CAS  Google Scholar 

  • Covey AM, Sofocleous CT, 2008. Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer. Semin Intervent Radiol, 25(4):406–412. https://doi.org/10.1055/s-0028-1102996

    Article  Google Scholar 

  • Detry O, Warzee F, Polus M, et al., 2003. Liver resection for noncolorectal, nonneuroendocrine metastases. Acta Chir Belg, 103(5):458–462. https://doi.org/10.1080/00015458.2003.11679467

    Article  CAS  Google Scholar 

  • Frezza EE, Wachtel MS, Barragan B, et al., 2007. The role of radiofrequency ablation in multiple liver metastases to debulk the tumor: a pilot study before alternative therapies. J Laparoendosc Adv Surg Tech A, 17(3):282–284. https://doi.org/10.1089/lap.2006.0100

    Article  Google Scholar 

  • Gillams AR, 2005. The use of radiofrequency in cancer. Br J Cancer, 92(10):1825–1829. https://doi.org/10.1038/sj.bjc.6602582

    Article  CAS  Google Scholar 

  • Golse N, Adam R, 2017. Liver metastases from breast cancer: what role for surgery? Indications and results. Clin Breast Cancer, 17(4):256–265. https://doi.org/10.1016/j.clbc.2016.12.012

    Article  Google Scholar 

  • Gunabushanam G, Sharma S, Thulkar S, et al., 2007. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. J Vasc Interv Radiol, 18(1):67–72. https://doi.org/10.1016/j.jvir.2006.10.014

    Article  Google Scholar 

  • Illing R, Gillams A, 2010. Radiofrequency ablation in the treatment of breast cancer liver metastases. Clin Oncol (R Coll Radilo), 22(9):781–784. https://doi.org/10.1016/j.clon.2010.08.004

    Article  CAS  Google Scholar 

  • Keil S, Bruners P, Ohnsorge L, et al., 2010. Semiautomated versus manual evaluation of liver metastases treated by radiofrequency ablation. J Vasc Interv Radiol, 21(2):245–251. https://doi.org/10.1016/j.jvir.2009.10.024

    Article  Google Scholar 

  • Kim ES, Scott LJ, 2017. Palbociclib: a review in HR-positive, HER2-negative, advanced or metastatic breast cancer. Target Oncol, 12(3):373–383. https://doi.org/10.1007/s11523-017-0492-7

    Article  Google Scholar 

  • Kümler I, Parner VK, Tuxen MK, et al., 2015. Clinical outcome of percutaneous RFA-ablation of non-operable patients with liver metastasis from breast cancer. Radiol Med, 120(6):536–541. https://doi.org/10.1007/s11547-014-0489-6

    Article  Google Scholar 

  • Lai C, Jin RA, Liang X, et al., 2016. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(3):236–246. https://doi.org/10.1631/jzus.B1500322

    Article  Google Scholar 

  • Lee HY, Ko HK, Kim SH, et al., 2013. Percutaneous radiofrequency ablation for liver metastases in breast cancer patients. Breast J, 19(5):563–565. https://doi.org/10.1111/tbj.12170

    Article  Google Scholar 

  • Livraghi T, Goldberg SN, Solbiati L, et al., 2001. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology, 220(1):145–149. https://doi.org/10.1148/radiology.220.1.r01jl01145

    Article  CAS  Google Scholar 

  • Mansour M, Teo ZL, Luen SJ, et al., 2017. Advancing immunotherapy in metastatic breast cancer. Curr Treat Options Oncol, 18(6):35. https://doi.org/10.1007/s11864-017-0478-9

    Article  Google Scholar 

  • Meattini I, Desideri I, Francolini G, et al., 2017. Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature. Med Oncol, 34(5):74. https://doi.org/10.1007/s12032-017-0935-0

    Article  Google Scholar 

  • Meloni MF, Andreano A, Laeseke PF, et al., 2009. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation-intermediate and long-term survival rates. Radiology, 253(3):861–869. https://doi.org/10.1148/radiol.2533081968

    Article  Google Scholar 

  • Moher D, Liberati A, Tetzlaff J, et al., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 21:6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

    Google Scholar 

  • Nordmann AJ, Kasenda B, Briel M, 2012. Meta-analyses: what they can and cannot do. Swiss Med Wkly, 142: w13518. https://doi.org/10.4414/smw.2012.13518

    PubMed  Google Scholar 

  • Parmar MK, Torri V, Stewart L, 1998. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17(24):2815–2834.

    Article  CAS  Google Scholar 

  • Ruiterkamp J, Ernst MF, 2011. The role of surgery in metastatic breast cancer. Eur J Cancer, 47(S3): S6–S22. https://doi.org/10.1016/S0959-8049(11)70142-3

    Article  Google Scholar 

  • Samaan NA, Buzdar AU, Aldinger KA, et al., 1981. Estrogen receptor: a prognostic factor in breast cancer. Cancer, 47(3):554–560.

    Article  CAS  Google Scholar 

  • Sato T, Sato S, Kato K, et al., 2006. Two cases of radiofrequency ablation (RFA) therapy for control of liver metastases from breast cancer. Jpn J Cancer Chemother, 33(12):1904–1906 (in Japanese).

    Google Scholar 

  • Selzner M, Morse MA, Vredenburgh JJ, et al., 2000. Liver metastases from breast cancer: long-term survival after curative resection. Surgery, 127(4):383–389. https://doi.org/10.1067/msy.2000.103883

    Article  CAS  Google Scholar 

  • Sofocleous CT, Nascimento RG, Gonen M, et al., 2007. Radiofrequency ablation in the management of liver metastases from breast cancer. Am J Roentgenol, 189(4): 883–889. https://doi.org/10.2214/AJR.07.2198

    Article  CAS  Google Scholar 

  • Stang A, 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z

    Article  Google Scholar 

  • Travaini LL, Trifirò G, Ravasi L, et al., 2008. Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging, 35(7):1316–1322. https://doi.org/10.1007/s00259-008-0748-7

    Article  Google Scholar 

  • Treska V, Liska V, Skalicky T, et al., 2012. Non-colorectal liver metastases: surgical treatment options. Hepatogastroenterology, 59(113):245–248. https://doi.org/10.5754/hge10292

    PubMed  Google Scholar 

  • Treska V, Cerna M, Liska V, et al., 2014. Surgery for breast cancer liver metastases-factors determining results. Anticancer Res, 34(3):1281–1286.

    PubMed  Google Scholar 

  • Veltri A, Gazzera C, Barrera M, et al., 2014. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Radiol Med, 119(5):327–333. https://doi.org/10.1007/s11547-013-0354-z

    Article  Google Scholar 

  • Vogl TJ, Emam A, Naguib NN, et al., 2015. How effective are percutaneous liver-directed therapies in patients with non-colorectal liver metastases? Viszeralmedizin, 31(6): 406–413. https://doi.org/10.1159/000440677

    PubMed  PubMed Central  Google Scholar 

  • Wong J, Cooper A, 2016. Local ablation for solid tumor liver metastases: techniques and treatment efficacy. Cancer Control, 23(1):30–35. https://doi.org/10.1177/107327481602300106

    Article  Google Scholar 

  • Yun BL, Lee JM, Baek JH, et al., 2011. Radiofrequency ablation for treating liver metastases from a noncolorectal origin. Korean J Radiol, 12(5):579–587. https://doi.org/10.3348/kjr.2011.12.5.579

    Article  Google Scholar 

  • Zhang J, Liu Y, 2008. HER2 over-expression and response to different chemotherapy regimens in breast cancer. J Zhejiang Univ Sci B, 9(1):5–9. https://doi.org/10.1631/jzus.B073003

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all our colleagues from the Second Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China) for their help and support in this study.

Author information

Authors and Affiliations

  1. Department of Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China

    Yi-bin Xiao, Bo Zhang & Yu-lian Wu

Authors
  1. Yi-bin Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-lian Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu-lian Wu.

Additional information

This article has been retracted. Please see the retraction notice for more detail:https://doi.org/10.1631/jzus.B17r0516

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, Yb., Zhang, B. & Wu, Yl. RETRACTED ARTICLE: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis. J. Zhejiang Univ. Sci. B 19, 829–843 (2018). https://doi.org/10.1631/jzus.B1700516

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1700516

Key words

关键词

CLC number

Search

Navigation